Artificial intelligence is increasingly being applied across early-stage drug discovery, but translating computational p...
Drug delivery technologies have become increasingly important as pharmaceutical developers work with complex molecules, ...
Akeso has received clinical trial clearance from China’s Center for Drug Evaluation for AK157D1, a next-generation...
CureGene has dosed the first participant in an Australian Phase I clinical trial of CG-0416, an investigational oral liv...
The Obesity and Metabolic Surgery Society of India and the Endocrine Society of India have issued their first joint cons...
Brown University Health and Arcamyra Therapeutics are preparing to launch a Phase I clinical trial of ACM-CpG in patient...
Apodex has launched TRACES, a benchmark designed to evaluate how artificial intelligence systems perform on open-ended s...
South Korean biopharmaceutical company Dx&Vx has signed two material transfer agreements in Latin America for its KR...
Ascletis Pharma has initiated two Phase I studies in the United States evaluating investigational once-monthly injectabl...
Scientists at Northwestern University have found that tissue environments surrounding persistent viral reservoirs share ...
Researchers at Stony Brook Cancer Center have developed an experimental RNA-based therapy that reduced non-small cell lu...
Suzhou Ribo Life Science and its subsidiary Ribocure Pharmaceuticals have reported positive Phase IIa results for vortos...
Shanghai Ark Biopharmaceutical, or ArkBio, has completed dosing across all healthy-volunteer cohorts in an Australian Ph...
CPHI South East Asia 2026 brought together more than 11,000 pharmaceutical professionals from over 70 countries at the Q...
Kelun-Biotech has received approval from the Center for Drug Evaluation of China’s National Medical Products Admin...
Hong Kong headquartered Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discover...
Suzhou Ribo Life Science and subsidiary Ribocure Pharmaceuticals have reported positive Phase 2a data for vortosiran, an...
Innovent Biologics and Spero Therapeutics have entered into an exclusive licence agreement for IBI355, also known as SP0...
HUYABIO International has reported statistically significant and clinically meaningful topline Phase 3 results for HBI-8...
Insmed has reported positive 12-month data from the ongoing open-label extension study of treprostinil palmitil inhalati...
Drug development is approaching a significant inflection point. Advances in induced pluripotent stem cells (iPSCs), orga...
Maxona Pharmaceuticals has received U.S. FDA clearance of its Investigational New Drug application for a Phase 2 clinica...
The pharmaceutical industry’s innovation equation is changing. Developing an entirely new molecu...
Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
Lynk Pharmaceuticals has completed patient enrolment in its Phase III clinical trial of zemprocitinib capsules for activ...
